Will 2023 be the year that the UK finally becomes a 'science superpower'?
We have previously noted that 2023 may be a blockbuster year for European biotech deal making. A recent article in the Financial Times examines the…
Source: lexology.com
Page 26 - Access Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Access Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Access Pathway Today - Breaking & Trending Today
Psychedelic research: evaluating the regulatory roadmap
Aman Khera and Dr Christine Moore of Worldwide Clinical Trials share how regulatory agencies are supporting psychedelic research.
Source: europeanpharmaceuticalreview.com
Canadian and US developers to trial psychedelic medicines in UK
Canadian and US developers of psychedelic medicines for mental health conditions have signed with a CMO to trial their drugs in the UK.
Source: europeanpharmaceuticalreview.com
Investegate |COMPASS Pathways Announcements | COMPASS Pathways: COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP
Investegate announcements from COMPASS Pathways, COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP
Source: investegate.co.uk
Latest Updates of 12 Viva's Portfolio Companies
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
Source: prnewswire.com